Neulastim 1 Syringe 6 mg/0,6 ml

Neulastim 1 Syringe 6 mg/0,6 ml

See More by Amgen

Format:

1 Syringe — 6 mg/0,6 ml

Use for:

Neulastim is a medicine used to treat neutropenia, a condition characterized by a low number of neutrophils, a type of white blood cells. It helps to increase the body's production of neutrophils, helping to protect against infection.

Note:

Turkish packaging

Active ingredient: Pegfilgrastim

Price:

$4689

Neulastim is the first and only FDA-approved growth factor for the treatment of chemotherapy-induced neutropenia (CIN). Neulastim works by stimulating the production of neutrophils, which are a type of white blood cell that helps fight off infections. Neulastim is administered through a single subcutaneous injection, either once every two weeks or every three weeks. Neulastim helps reduce the risk of infections associated with CIN, allowing patients to receive more intensive chemotherapy, resulting in improved outcomes. Neulastim is a safe and effective treatment for CIN, and has been clinically proven to reduce the duration of neutropenia and the need for hospitalization. Neulastim has a well-established safety profile, with minimal side effects.

It is easy to use, and has been shown to reduce the risk of infection and improve patients’ quality of life.